J Am Pharm Assoc (2003). 2022 Mar-Apr;62(2):580-587.e1. doi: 10.1016/j.japh.2021.09.015. Epub 2021 Oct 2.
Primary care may offer innovations in delivering comprehensive medication reviews (CMRs).
This study aimed to (1) describe innovations to improve delivery and impact of CMR, (2) quantify CMR completion rates and patient satisfaction, and (3) characterize medication changes and impact on medication costs.
Board-certified ambulatory care pharmacists with collaborative practice agreements embedded in primary care provided CMRs in 5 clinics for eligible university prescription plan retirees.
Innovations included (1) physician review of potential CMR recipient list, (2) use of trained student pharmacists to recruit and set up CMR visits, (3) use of clinical information in a standardized CMR 2-visit approach by embedded pharmacists, and (4) enrollment into disease management programs or referrals to other providers.
Data from a retrospective cohort were collected. The CMR completion rate and therapeutic interventions were documented. Prescription fill data were available for 6 months before and after the CMR. An anonymous survey assessed patient satisfaction. Frequencies and descriptive statistics characterized completion rate, interventions, and patient satisfaction. The median cost to the plan of deleted versus added medications and per member per month total drug costs before and after the CMR were compared.
Among 729 beneficiaries screened, 489 were eligible and 223 (46%) received a CMR. There were 388 medication interventions: the most common intervention was to delete medications (41.0%). One in 4 was enrolled into the pharmacists' disease management programs. Individuals reported 4.68 (SD 0.67) of 5 for helpfulness of the CMR. The ratio of median costs for medication deletions versus additions was $1.46 vs. $1.00.
Innovations to deliver CMRs capitalized on well-established physician-pharmacist relationships and nonpharmacist personnel to recruit and prepare the intake. Almost half of eligible beneficiaries received a CMR, and the CMRs were impactful for patients and payers. The most prevalent intervention was to discontinue medications for efficacy reasons.
初级保健可能在提供全面药物审查(CMR)方面提供创新。
本研究旨在:(1)描述提高 CMR 交付和影响的创新措施;(2)量化 CMR 完成率和患者满意度;(3)描述药物变化并评估对药物成本的影响。
具有协作实践协议的认证的门诊护理药剂师在 5 家诊所为符合条件的大学处方计划退休人员提供 CMR。
创新措施包括:(1)医生审查潜在 CMR 受助人名单;(2)使用培训过的学生药剂师招募并安排 CMR 就诊;(3)在嵌入药剂师的标准化 CMR 2 次就诊方法中使用临床信息;(4)参加疾病管理计划或转介给其他提供者。
收集了回顾性队列的数据。记录 CMR 完成率和治疗干预措施。CMR 前后 6 个月的处方填写数据可用。匿名调查评估了患者满意度。频率和描述性统计描述了完成率、干预措施和患者满意度。比较了 CMR 前后删除和添加药物的计划成本中位数以及每个成员每月的总药物成本。
在筛选的 729 名受益人中,有 489 名符合条件,有 223 名(46%)接受了 CMR。共有 388 项药物干预措施:最常见的干预措施是删除药物(41.0%)。四分之一的人参加了药剂师的疾病管理计划。个人报告 CMR 的有用性为 4.68(SD 0.67)。删除药物与添加药物的中位数成本比为 1.46 比 1.00。
提供 CMR 的创新措施利用了成熟的医生-药剂师关系和非药剂师人员来招募和准备摄入量。几乎一半的合格受益人接受了 CMR,CMR 对患者和支付者都具有影响力。最常见的干预措施是出于疗效原因停止用药。